We observed from immunohistological analysis that Cav1 expression was enhanced in endothelial cells within SHH-MB tumour regions when mice were treated with FiVis nanoparticles (Fig. 3a–c and quantified in Supplementary Fig. 1). Here, CAV1 is linked to neoplasm.